DBDaniele Birreci

Daniele Birreci

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniele Birreci has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The classificatory ambiguity of task-specific tremor

    by Daniele Birreci, Luca Angelini, Simone Aloisio, Anna S. Grandolfo, Martina De Riggi, Alberto J. Espay, Matteo Bologna

  • Open Access

    Cortical adaptation following motor fatigue: Dynamic changes in primary motor cortex excitability in healthy young adults

    by Simone Aloisio, Massimiliano Passaretti, Martina De Riggi, Daniele Birreci, Anna Sofia Grandolfo, Sara Cirinei, Luca Angelini, Matteo Bologna

  • Open Access

    Driving Cerebellar Theta Oscillations Interferes With Voluntary Neck Movements in Cervical Dystonia

    by Davide Costa, Andrea Guerra, Daniele Birreci, Massimiliano Passaretti, Martina De Riggi, Anna Sofia Grandolfo, Valentina D'ONofrio, Luca Angelini, Giulia Paparella, Matteo Bologna

    Background: Cervical dystonia (CD) is a movement disorder with a complex pathophysiology, including cerebellar abnormalities. Transcranial alternating current stimulation (tACS), a noninvasive neuromodulation technique capable of entraining brain oscillations, can transiently modulate neuronal activity and enhance resonant rhythms. Objective: The aim of this study was to explore whether cerebellar tACS delivered at specific cerebellar‐resonant frequencies modifies fast voluntary neck movements in patients with CD and whether botulinum toxin (BoNT) therapy influences tACS effects. Methods: Eighteen patients with CD, predominantly exhibiting the torticollis phenotype, were included. Fast voluntary neck movements were objectively assessed using motion analysis during two experimental sessions: (1) pre‐BoNT and (2) 1 month after BoNT. Cerebellar tACS was applied at theta (θ), beta (β), and gamma (γ) frequencies, along with sham stimulation, while patients performed fast neck movements. Peak angular velocity and angular amplitude of both prodystonic and antidystonic movements were measured. Results: In the OFF‐BoNT state, neck (antidystonic) movements' velocity and amplitude decreased with θ‐tACS, particularly when stimulation was applied to the cerebellar hemisphere ipsilateral to the side of torticollis. BoNT ameliorated movement velocity and amplitude, but it did not change the detrimental effect of cerebellar θ oscillations on antidystonic movements. Conclusions: Driving cerebellar θ oscillations interferes with the execution of fast voluntary neck movements in CD, and BoNT therapy does not influence this effect. These findings support the view of dystonia as a network disorder in which the cerebellum plays a key role. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

  • Open Access

    Pattern Changes and Recurrent Remissions in Cervical Dystonia: Insights from a Long-Term Treated Case

    by Simone Aloisio, Massimiliano Passaretti, Luca Angelini, Martina De Riggi, Francesca Santachiara, Anna Sofia Grandolfo, Daniele Birreci, Matteo Bologna

    Cervical dystonia (CD) is increasingly recognized as a disorder with a dynamic clinical course rather than a fixed phenomenological profile. This report describes the long-term observation of a man with isolated CD followed for nearly 12 years from symptom onset. The course was characterized by multiple pattern changes, including a clear shift from left- to right-sided torticollis in 2019, followed by alternating and mixed dystonic patterns. Three remission phases were documented during follow-up: two prolonged periods in 2017–2018 and 2020–2021, and a further phase from March to November 2022. Over time, treatment requirements decreased from higher initial doses (500–700 U abobotulinumtoxinA and up to 130 U onabotulinumtoxinA) to lower maintenance doses of 30–50 U incobotulinumtoxinA/onabotulinumtoxinA, with longer injection intervals and no obvious documented need for dose adjustment to maintain clinical responsiveness. This case highlights the coexistence of pattern changes and recurrent remissions within a single continuously followed patient over an unusually long period. Although a treatment-related mechanism remains speculative and alternative explanations cannot be excluded, the observation underscores the value of prolonged follow-up and individualized treatment strategies in CD.

  • Open Access

    Is There a Relationship Between Movement and Sleep Disturbances in Essential Tremor?

    by Giulia Paparella, Adriana Martini, Anna Sofia Grandolfo, Matteo Panfili, Luca Angelini, Martina De Riggi, Simone Aloisio, Daniele Birreci, Annalisa Maraone, Francesco Saverio Bersani, et al.

    Background: Essential tremor (ET) is a clinically heterogeneous disorder involving motor and non-motor features. Voluntary movement abnormalities, including movement slowness (bradykinesia), have been frequently described in ET. Among non-motor symptoms, insomnia is also frequently reported, raising the possibility of shared underlying mechanisms with bradykinesia (e.g., brainstem noradrenergic dysfunction involving the locus coeruleus due to Lewy body pathology). We investigated the relationship between movement abnormalities, as objectively quantified using finger-tapping kinematic analysis, and sleep disturbances in ET. Methods: A subsample of 29 ET patients included in a previous study underwent kinematic analysis of finger-tapping. Insomnia was evaluated using the Insomnia Severity Index (ISI). Patients were stratified according to the presence of bradykinesia (e.g, movement slowness during finger-tapping) and insomnia (ISI ≥ 8). Group comparisons and correlational analyses were performed to assess the association between kinematic measures of bradykinesia, insomnia severity and other clinical features. Results: Fourteen subjects (48.3%) exhibited bradykinesia on kinematic analysis, and eleven patients (37.9%) met the criteria for insomnia. The prevalence of insomnia was similar between patients with and without bradykinesia. Likewise, no significant differences in finger-tapping kinematics were observed between ET patients with and without insomnia. Kinematic measures of bradykinesia did not correlate with ISI scores (all p > 0.05), whereas ISI scores were significantly positively correlated with clinical tremor severity. Conclusions: The current kinematic analysis suggests no relationship between movement abnormalities and sleep disturbances in ET. While bradykinesia in ET possibly relies on the dysfunction of cerebellar–basal ganglia circuits, insomnia in ET may reflect prominent brainstem dysfunction. Larger studies integrating kinematic assessments, neuroimaging, and longitudinal designs are needed to clarify the relationship between movement and sleep disturbances in ET

  • Open Access

    Orofacial Drinking Tremor: A Case Series and Literature Review

    by Daniele Birreci, Luca Angelini, Simone Aloisio, Anna S. Grandolfo, Sara Cirinei, Adriana Martini, Martina De Riggi, Matteo Bologna

    Background: Task‐specific orofacial tremor is a rare condition in which rhythmic oscillations of orofacial muscles occur during specific actions. Drinking tremor represents a recurrent pattern in isolated reports, although its phenomenology and underlying mechanisms remain incompletely defined. Cases: We report three cases of orofacial drinking tremor, each showing a different pattern. Differences involved the distribution of orofacial muscle activity and the presence of additional signs, including tremor in other body regions or subtle dystonic postures. Variability in task dependence, posture sensitivity, and sensory modulation contributed to the heterogeneity of these presentations. Literature Review: Published reports describe a spectrum of orofacial drinking tremors, ranging from strictly task‐specific patterns to mixed task‐ and position‐dependent presentations. Some patients exhibit subtle dystonic features, whereas others show no clear additional neurological signs. Electrophysiology typically demonstrates regular 5–8 Hz rhythmic discharges in the orofacial muscles. Systemic pharmacological therapies offer limited benefit, whereas botulinum toxin remains the most effective option. Conclusions: Current evidence suggests that orofacial drinking tremor does not represent a single clinical entity. An approach integrating detailed phenomenological characterization with plausible pathophysiological mechanisms may improve diagnostic interpretation and guide individualized management strategies.


  • Open Access

    Neurophysiological assessment of manual dexterity in healthy subjects

    by Martina De Riggi, Daniele Birreci, Anna Sofia Grandolfo, Luca Angelini, Simone Aloisio, Antonio Cannavacciuolo, Giulia Paparella, Matteo Bologna

  • Open Access

    Analyzing the ‘Bradykinesia Complex’ in Parkinson's Disease

    by Giulia Paparella, Martina De Riggi, Antonio Cannavacciuolo, Daniele Birreci, Davide Costa, Luca Angelini, Danilo Alunni Fegatelli, Alfonso Fasano, Alberto J. Espay, Matteo Bologna

    Background: Bradykinesia is the hallmark sign of parkinsonism. We recently proposed redefining bradykinesia as a complex of motor abnormalities, each reflecting separate pathophysiological elements. Objective: To analyze the ‘bradykinesia complex’ in Parkinson's disease (PD) and healthy elderly individuals. Methods: We conducted a finger‐tapping kinematic analysis in 350 individuals (192 PD patients OFF medication and 158 healthy controls). A subsample of 129 patients was also tested ON medication. Group comparisons were followed by unsupervised clustering. Receiver operating characteristic (ROC) analyses defined optimal kinematic cut‐offs to detect individual motor abnormalities. We then quantified the prevalence and combinations of these features per subject. Using Bayes' theorem, we estimated the probability of PD based on the observed combination of bradykinesia features. Regression analyses served to identify predictors of kinematic alterations. Results: Patients exhibited reduced velocity and amplitude as well as altered rhythm and sequence effect compared with controls (all P‐ values < 0.001). Cluster analysis revealed substantial group overlap. ROC analyses showed that bradykinesia (movement slowness) was the most common and accurate feature for distinguishing PD, with its diagnostic power improving when combined with other motor abnormalities (hypokinesia, dysrhythmia, sequence effect). The likelihood of correctly identifying PD increased with the number of observed abnormalities, reaching up to 95% when all features were present. Levodopa improved motor performance, but the motor abnormality patterns remained unchanged. Conclusions: The detailed bradykinesia features assessment was crucial for differentiating PD individuals from controls. Diagnostic accuracy requires considering multiple motor abnormalities together, irrespective of the specific combination. Advancing our understanding of the ‘bradykinesia complex’ has clinical and pathophysiological implications. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.


  • Open Access

    Pathophysiological Role of Primary Motor Cortex in Essential Tremor

    by Daniele Birreci, Luca Angelini, Giulia Paparella, Davide Costa, Antonio Cannavacciuolo, Massimiliano Passaretti, Martina De Riggi, Simone Aloisio, Donato Colella, Andrea Guerra, et al.

    Background: Essential tremor (ET) is one of the most prevalent movement disorders. However, the complete understanding of ET pathophysiology remains elusive. Objective: To explore the pathophysiological role of primary motor cortex (M1) in ET, specifically exploring its neurophysiological changes and their correlation with voluntary motor abnormalities. Methods: We recruited 30 ET patients and 18 healthy controls (HC). Evaluations were conducted on patients using clinical scales. Transcranial magnetic stimulation (TMS) was used to assess M1 excitability, including motor thresholds and motor evoked potentials (MEPs) input/output curve, together with intracortical excitability measures. Long‐term potentiation (LTP)‐like plasticity of M1 was tested using intermittent theta‐burst stimulation (iTBS). Objective assessments of tremor and voluntary movement execution during finger‐tapping were conducted through kinematic analysis. Finally, we explored the potential relationship between TMS, clinical, and kinematic data. Results: Compared with HC, ET patients had lower excitability, intracortical inhibition, and lower LTP‐like plasticity of M1. ET patients also exhibited slower finger‐tapping performance compared with HC. Among ET patients, the degree of movement slowing during finger‐tapping correlated with alterations in corticospinal excitability. Specifically, reduced M1 excitability was associated with lower finger‐tapping velocity. No other correlations were found. Conclusions: The study findings reveal neurophysiological alterations of M1 in ET and demonstrate correlations between excitability measures and voluntary motor performance. These results provide novel insight into the pathophysiology of ET, emphasizing the role of M1 changes in this condition. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.


  • Open Access

    The Whistle‐Smile Reflex in Parkinson's Disease: A Cross‐Sectional Study

    by Giulia Paparella, Luca Marsili, Kevin R. Duque, Lucrezia Balestrucci, Adriana Martini, Antonio Cannavacciuolo, Davide Costa, Daniele Birreci, Martina De Riggi, Luca Angelini, et al.